Showing results (231-240 of 328) with videos related to
Sort By:
Pageof 33
Journal of the American College of Cardiology|February 11, 2012
Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008J Matthew Brennan, David Dai, Manesh R Patel, et al.The New England Journal of Medicine|February 21, 2009
Quality of life after late invasive therapy for occluded arteriesDaniel B Mark, Wenqin Pan, Nancy E Clapp-Channing, et al.Stroke|September 13, 2014
Racial/Ethnic differences in process of care and outcomes among patients hospitalized with intracerebral hemorrhageYing Xian, Robert G Holloway, Eric E Smith, et al.American Heart Journal|September 11, 2013
Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women)Connie N Hess, Sunil V Rao, David F Kong, et al.Circulation. Arrhythmia and Electrophysiology|December 16, 2014
Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patientsSean D Pokorney, Anne S Hellkamp, Clyde W Yancy, et al.Circulation|July 5, 2006
Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Daniel B Mark, Charlotte L Nelson, Kevin J Anstrom, et al.JACC. Cardiovascular Interventions|February 5, 2010
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)Martin B Leon, David E Kandzari, Eric L Eisenstein, et al.Journal of the American College of Cardiology|July 25, 2020
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFTJeanne E Poole, Brian Olshansky, Daniel B Mark, et al.European Journal of Heart Failure|March 29, 2019
Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk scoreChristopher O'Connor, Mona Fiuzat, Hillary Mulder, et al.Contemporary Clinical Trials Communications|February 1, 2024
Evaluating registry-based trial economics: Results from the STRESS clinical trialEric L Eisenstein, Kevin D Hill, Nancy Wood, et al.Pageof 33